Canada markets closed

Cytek Biosciences, Inc. (CTKB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.27-0.11 (-1.72%)
At close: 04:00PM EDT
6.27 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 838.78M
Enterprise Value 590.50M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)4.48
Price/Book (mrq)2.13
Enterprise Value/Revenue 3.06
Enterprise Value/EBITDA -133.96

Trading Information

Stock Price History

Beta (5Y Monthly) 1.37
52-Week Change 3-28.03%
S&P500 52-Week Change 325.38%
52 Week High 310.90
52 Week Low 33.80
50-Day Moving Average 36.67
200-Day Moving Average 37.14

Share Statistics

Avg Vol (3 month) 3721.23k
Avg Vol (10 day) 3615.8k
Shares Outstanding 5131.26M
Implied Shares Outstanding 6131.26M
Float 8105.85M
% Held by Insiders 18.71%
% Held by Institutions 165.03%
Shares Short (Apr 15, 2024) 47.47M
Short Ratio (Apr 15, 2024) 410.02
Short % of Float (Apr 15, 2024) 47.29%
Short % of Shares Outstanding (Apr 15, 2024) 45.69%
Shares Short (prior month Mar 15, 2024) 48.51M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -6.29%
Operating Margin (ttm)-0.23%

Management Effectiveness

Return on Assets (ttm)-3.25%
Return on Equity (ttm)-2.97%

Income Statement

Revenue (ttm)193.02M
Revenue Per Share (ttm)1.43
Quarterly Revenue Growth (yoy)20.50%
Gross Profit (ttm)N/A
EBITDA -20.3M
Net Income Avi to Common (ttm)-12.15M
Diluted EPS (ttm)-0.09
Quarterly Earnings Growth (yoy)64.50%

Balance Sheet

Total Cash (mrq)262.41M
Total Cash Per Share (mrq)2.01
Total Debt (mrq)14.14M
Total Debt/Equity (mrq)3.60%
Current Ratio (mrq)6.97
Book Value Per Share (mrq)3.01

Cash Flow Statement

Operating Cash Flow (ttm)5.28M
Levered Free Cash Flow (ttm)-400k